Charatcharoenwitthaya Natthinee, Jaisamrarn Unnop, Songpatanasilp Thawee, Kuptniratsaikul Vilai, Unnanuntana Aasis, Sritara Chanika, Nimitphong Hataikarn, Wattanachanya Lalita, Chotiyarnwong Pojchong, Amphansap Tanawat, Phruetthiphat Ong-Art, Valleenukul Thanut, Chaiamnuay Sumapa, Petchlorlian Aisawan, Srinonprasert Varalak, Tejavanija Sirakarn, Kitisomprayoonkul Wasuwat, Dajpratham Piyapat, Chaikittisilpa Sukanya, Somboonporn Woraluk
Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Thammasat University, 99/209 Pahonyothin Road., Pathumthani, 12120, Thailand.
Menopause Research Group, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, 1873 Rama 4 Road, Bangkok, 10330, Thailand.
Osteoporos Sarcopenia. 2023 Jun;9(2):45-52. doi: 10.1016/j.afos.2023.06.001. Epub 2023 Jun 20.
The Thai Osteoporosis Foundation (TOPF) is an academic organization that consists of a multidisciplinary group of healthcare professionals managing osteoporosis. The first clinical practice guideline for diagnosing and managing osteoporosis in Thailand was published by the TOPF in 2010, then updated in 2016 and 2021. This paper presents important updates of the guideline for the diagnosis and management of osteoporosis in Thailand.
A panel of experts in the field of osteoporosis was recruited by the TOPF to review and update the TOPF position statement from 2016. Evidence was searched using the MEDLINE database through PubMed. Primary writers submitted their first drafts, which were reviewed, discussed, and integrated into the final document. Recommendations are based on reviews of the clinical evidence and experts' opinions. The recommendations are classified using the Grading of Recommendations, Assessment, Development, and Evaluation classification system.
The updated guideline comprises 90 recommendations divided into 12 main topics. This paper summarizes the recommendations focused on 4 main topics: the diagnosis and evaluation of osteoporosis, fracture risk assessment and indications for bone mineral density measurement, fracture risk categorization, management according to fracture risk, and pharmacological management of osteoporosis.
This updated clinical practice guideline is a practical tool to assist healthcare professionals in diagnosing, evaluating, and managing osteoporosis in Thailand.
泰国骨质疏松症基金会（TOPF）是一个学术组织，由管理骨质疏松症的多学科医疗专业人员组成。TOPF于2010年发布了泰国首个骨质疏松症诊断和管理临床实践指南，随后在2016年和2021年进行了更新。本文介绍了泰国骨质疏松症诊断和管理指南的重要更新内容。
TOPF招募了骨质疏松症领域的专家小组，以审查和更新2016年的TOPF立场声明。通过PubMed使用MEDLINE数据库检索证据。主要作者提交初稿，经过审查、讨论后整合到最终文件中。建议基于对临床证据的审查和专家意见。建议使用推荐分级、评估、制定和评价分类系统进行分类。
更新后的指南包括90条建议，分为12个主要主题。本文总结了聚焦于4个主要主题的建议：骨质疏松症的诊断和评估、骨折风险评估及骨密度测量指征、骨折风险分类、根据骨折风险进行管理以及骨质疏松症的药物治疗。
这份更新后的临床实践指南是协助泰国医疗专业人员诊断、评估和管理骨质疏松症的实用工具。
